European Journal of Dermatology
MENUPyoderma gangrenosum possibly triggered by adalimumab Volume 22, issue 6, November-December 2012
Figures
Nobuyuki Kikuchi, Tomoko Hiraiwa, Takenobu Ohashi, Yuka Hanami, Masataka Satoh, Hideo Takenoshita, Toshiyuki Yamamoto
Department of Dermatology,
Fukushima Medical University,
Fukushima 960-1295, Japan
- DOI : 10.1684/ejd.2012.1849
- Page(s) : 804-5
- Published in: 2012
ejd.2012.1849 Auteur(s) : Nobuyuki Kikuchi nobuyuk@fmu.ac.jp, Tomoko Hiraiwa, Takenobu Ohashi, Yuka Hanami, Masataka Satoh, Hideo Takenoshita, Toshiyuki Yamamoto Department of Dermatology, Fukushima Medical University, Fukushima 960-1295, Japan Therapies for pyoderma gangrenosum (PG) include glucocorticosteroids, steroid-sparing immunosuppressive agents, immunomodulators, antimicrobial agents, intravenous immunoglobulin, and granulocyte apheresis [1, 2]. Recently, several papers have shown [...]